Since the first sequencing of the human genome in 2003, tremendous gains have been made in identifying genetic mutations related to cancer and genetic tests to assess a person’s inherited risk of developing certain cancers are abundant. However, the tests are not clinically actionable for most healthy people. Genetic mutations measure population risk, not individual risk. Genetic mutations (SNPs) identify increased disease risk, but their presence doesn’t guarantee disease will occur, and their absence doesn’t guarantee disease will not occur. There is no way to accurately predict who will get cancer. We are still missing a piece of the genomics puzzle.

Orbit Genomics analyzes a different part of your DNA that uniquely reflects both inherited predisposition to disease and the risk you’ve acquired from living. We’ve discovered a key missing piece of the genomics puzzle.